Inve US ▾
OHOHI

Omega Healthcare Investors (OHI) Q2 FY26 earnings call: guidance and Q&A

Earnings call· Jun 2026 (Q2 FY26)· Real Estate· Jul 30, 2026

Source: earnings call transcript

Executive summary

Omega Healthcare Investors Q2 FY26 — Strategic Portfolio Management and Strong Investment Pipeline

Omega Healthcare Investors delivered a quarter marked by strategic portfolio management and a strong outlook for future growth, despite sequential earnings being flat due to significant asset dispositions. The company successfully strengthened its balance sheet and operator credit profiles through proactive sales and transitions, while building a robust investment pipeline, particularly in RIDEA structures and UK care homes. Management expressed high confidence in the team's ability to drive accretive growth, leveraging a strong cost of capital and secular tailwinds.

Highlights

5

  • Adjusted FFO of $0.83 per share and FAD of $0.78 per share, reflecting strong year-over-year growth.

  • Trailing 12-month operator EBITDAR coverage improved to 1.65x as of March 31, 2026, up from 1.58x in Q4 2025.

  • Leverage decreased to 3.3x, reaching historically low levels, with fixed charge coverage at 6.5x.

  • Increased and tightened full-year adjusted FFO guidance to $3.22-$3.26 per share, up $0.02 at the midpoint.

  • Closed $470 million in new investments year-to-date, with a robust pipeline expected to drive significant transaction volume through year-end and into 2027.

Concerns

3

  • Sequential AFFO and FAD were flat due to a $563 million headwind from asset sales in Q2.

  • The timing of asset sales and loan repayments is expected to create a temporary earnings headwind in Q3.

  • Regulatory focus on fraud and abuse in healthcare, while not directly impacting nursing homes yet, is being watched for indirect impacts from state budget constraints.

Guidance & targets

CategoryTargetConfidence
Adjusted FFO per share
$3.22 to $3.26 per share
high materiality
High

Orderbook & backlog

Investment pipeline Robust Q2 FY26

Expected to drive a material pickup in transactions through year-end 2026 and into 2027, including market and off-market opportunities in U.S. and U.K., with a large component being RIDEA.

Investment volume under contract Meaningful increase Q2 FY26

Based on transactions forecasted to close in the coming months.

Disposition volume remaining $15 million to $25 million per quarter

Ongoing asset sales as part of portfolio pruning and strengthening.

Deals & partnerships

CommuniCare Strategic exit of 18 facilities located in Maryland and West Virginia. $480 million

Driven by strong pricing received for these facilities, combined with the ability to significantly improve Omega's credit with CommuniCare.

Ciena, Saber, HHC Transition of 20 facilities from Ciena to two other current operators, Saber and HHC. 18 facilities to Saber master lease, 1 facility to HHC master lease, and 1 facility sold to Saber Propco JV. Ciena also agreed to exit 8 owned Laurel assets through a sale to Saber Propco JV.

Proactive portfolio management by Omega; Ciena's Laurels portfolio had historically weighed down performance with trailing 12-month EBITDAR coverage of 0.87x on allocated rent of $33 million.

Saber Propco JV Acquisition of nine skilled nursing facilities in the Laurels portfolio. $160 million

Omega owns a 49% equity interest in the Saber Propco JV. Expected to achieve additional growth via improvements of same-store financial performance and future new deal transactions.

Omega-owned care homes operator Acquisition of the operations of four Omega-owned care homes in the U.K., converting the investment into a RIDEA structure. $20 million

First RIDEA investment in the U.K. This transaction was not converted due to operator issues, but rather for an opportunity for enhanced accretive growth.

Various Acquisition of three Rhode Island senior housing communities. $43 million

Part of new investments in Q2 2026.

Various Acquisition of two Indiana skilled nursing facilities. $33 million

Part of new investments in Q2 2026.

Various Purchase of a Tennessee senior housing community. $15 million

Part of new investments in Q2 2026.

Various Purchase of a U.K. care home. $11 million

Part of new investments in Q2 2026.

Various Purchase of a Texas skilled nursing facility. $8 million

Part of new investments in Q2 2026.

Various Real estate loans. $16 million

Part of new investments in Q2 2026.

Various Purchase of six Texas skilled nursing facilities. $73 million

Subsequent to quarter end, under a triple net structure.

Risks & headwinds

Temporary earnings headwind due to timing of asset sales and loan repayments Q3 FY26

Impacted Q2 AFFO growth; expected to create a temporary earnings headwind in Q3.

Mitigation:Proceeds position Omega for meaningful deployment opportunities supporting stronger growth in Q4 and into 2027.

Indirect impact from regulatory focus on fraud and abuse in healthcare Ongoing

Watching carefully for any indirect impact to nursing home space caused by state budget constraints; no material impact to coverages from negative state rate-setting outcomes to date.

Mitigation:Management applauds efforts to reduce fraud and abuse, hoping efforts focus on bad actors and that upstanding providers aren't inadvertently impacted.

What to watch in Q3 FY26

Earnings accretion from redeployed asset sale proceeds

Q3 FY26 (impact), Q4 FY26 and into FY27 (growth)
Current Q2 AFFO flat sequentially due to $563M asset sales
Target Stronger growth in Q4 and into 2027

Why it matters

Verifies the success of the strategic asset sales and capital recycling strategy.

However, we believe those proceeds position us for meaningful deployment opportunities that support stronger growth in Q4 and into 2027.

Find out whether OHI delivers this. Inve re-checks your case every morning.

Q&A highlights

Why did the operator agree to shift to RIDEA given high EBITDAR coverage, and what are the dynamics for future UK RIDEA transitions?

Matthew Gourmand explained the operator sought to monetize value, and Omega saw an opportunity for outsized returns (low to mid-teen yields) while allowing the operator to de-risk. This aligns with Omega's goal of long-term alignment of interest with partners, and they will continue to seek such opportunities in the UK.

“my sense was that he had created a decent amount of money and value in this portfolio and was looking to monetize some of that. We obviously spent a decent amount of time trying to understand whether there was opportunity for further growth, and we're very comfortable with that. And then we're able to strike a price that will create outsized returns, so meaningfully more than our low to mid-teen returns, we believe, over time, while also allowing him to take a little bit of risk off the table.”

asked by Justin Haasbeek · answered by Matthew Gourmand

2 min read 6 chapters

Detailed narrative

Leadership Transition and Legacy

CEO Taylor Pickett and CFO Bob Stephenson announced their 100th and final earnings call, reflecting on 25+ years of industry evolution and Omega's growth. They highlighted the company's culture of intellectual rigor, conservative balance sheet management, and evolving capital allocation products, expressing confidence in the new leadership team under Matthew Gourmand to maximize value over the next decade.

Strategic Portfolio Management

Omega proactively managed its portfolio, including the strategic exit of 18 CommuniCare assets for $480 million at an effective 6.7% cash flow cap rate, significantly improving credit. Additionally, 20 Ciena facilities were transitioned to Saber and HHC, strengthening Ciena's credit profile and providing future growth opportunities through Omega's 9.9% ownership in Saber OpCo. This active management aims to enhance the portfolio and improve accretion.

Investment Activity and Pipeline

The company closed $470 million in new investments year-to-date, with $126 million in Q2 and $93 million subsequent to quarter-end. These included senior housing, skilled nursing, and UK care homes, with a notable first RIDEA investment in the UK. A strong pipeline of market and off-market opportunities, particularly in RIDEA structures, is expected to drive significant transaction volume through year-end 2026 and into 2027, with stabilized unlevered returns in the low double digits for triple net and low to mid-teens for RIDEA deals.

Balance Sheet Strength and Liquidity

Omega maintained a strong balance sheet with leverage at a historically low 3.3x and fixed charge coverage of 6.5x. Proceeds from asset sales and loan repayments ($700 million) were used to pay down the revolver to $6 million, providing significant liquidity and flexibility for future investments and debt maturities. As of June 30, the company had $39 million in available cash and $145 million in restricted cash, including $118 million for 1031 exchanges.

Industry Trends and Regulatory Environment

The nursing home industry recovered 14% of its workforce, reaching pre-pandemic levels by June 2026, a significant milestone. CMS is rolling out a risk-based survey process, and while some negative state rate-setting outcomes occurred, they are not expected to materially impact coverages. Management is monitoring the regulatory focus on fraud and abuse for indirect impacts on state budgets, applauding efforts to reduce fraud while hoping to avoid inadvertent impacts on upstanding providers.

RIDEA Strategy and Operator Partnerships

Omega is expanding its RIDEA strategy, including its first UK RIDEA investment, aiming for enhanced accretive growth. The company emphasizes aligning interests with operating partners, such as Saber, through creative deal structures and a focus on high-quality assets with growth opportunities. This approach prioritizes strong clinical care and rational capital allocation, with a willingness to grow with high-caliber operators even if it means increased concentration.

Summary of the company's earnings call; see how call summaries are prepared. Not investment advice.